Close Menu


The US District Court in Delaware has adopted Enzo's interpretation of patent language and rejected the defendants' argument to invalidate a key patent.

Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.

An 8 percent increase in Enzo Clinical Lab revenues was offset by a 9 percent decrease in Life Sciences revenues.

Hologic said in its Form 10-Q that Enzo sued the firm in March alleging infringement of a patent related to labeled nucleotides for use as diagnostic tools.

The appeals court reversed in part an earlier decision by aUSdistrict court that resulted in a $61 million award to Enzo, and remanded the case back to the district court.

The flow cytometry-based test is the first available for the firm's FlowScript platform and allows for the simultaneous analysis of multiple genes expressed in a single cell.

NEW YORK (GenomeWeb) – Enzo Biochem said on Thursday that revenues in its fiscal fourth quarter rose 7 percent year over year.

NEW YORK (GenomeWeb) – Enzo Biochem today said that PerkinElmer will pay the firm $7 million as part of a legal settlement reached between the firms last week.

NEW YORK (GenomeWeb) – Enzo Biochem said on Monday that its revenues for its fiscal third quarter were up 6 percent year over year.

NEW YORK (GenomeWeb) – Affymetrix will pay $5.1 million to settle two decade-old cases with Enzo Biochem, Enzo said today.


Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.